Alliances

ParAllele and Affymetrix are now offering early technology access to ParAllele's MegAllele" genotyping reagents for use with Affymetrix GeneChip® arrays, enabling researchers to perform large-scale genotyping in their own labs with their own panels of single nucleotide polymorphisms (SNPs). The initial offering includes custom panels of 3,000 to 5,000 SNPs and standard panels of up to 10,000 pre-selected SNPs. Over time, the product portfolio will grow to include additional custom and standard products. Under the terms of the non-exclusive agreement, ParAllele will design assays and manufacture reagent kits and genotyping software while Affymetrix will market the integrated reagent kits and software together with its arrays and instrumentation.

ParAllele and SeraCare Life Sciences (who recently acquired substantially all of the assets of Genomics Collaborative, Inc.) have entered into an agreement which allows ParAllele to provide DNA samples in conjunction with our genotyping services. In this way, ParAllele will be able to provide all the elements of a genetic study. By offering collaborators immediate access to SeraCare's DNA repository, ParAllele can also facilitate the timely replication of genetic discoveries and extend these findings into other populations and conditions.